to : 30 October 2020
TransCure will be attending 4th Annual MarketsandMarkets Next Gen Immuno-Oncology congress
Our team will be in London during the 4th Annual MarketsandMarkets Next Gen Immuno-Oncology congress, October 29th to 30th.
Sebastien Tabruyn, our CSO, will be speaker during the conference. Do not miss his speech during the Pre-clinical & Translational Immuno-Oncology Developments Session, stream B – Immune Checkpoint Inhibitors. He will be presenting about Humanized Mouse Models for Immuno-Oncology Research at 11:25 – 11:55, October 30th.
Discover the full agenda here: Conference Agenda
Click here to pre-arrange a face-to-face :
Who are we?
TransCure bioServices is the European Leader CRO specialized in the Advanced Human Immune System Mouse (hu-mouse) Models. We provides in vivo pharmacology preclinical services for Cancer/Immuno-oncology, HIV, Inflammatory Bowel Diseases, Vaccines/Immunization, Immuno-safety…
Highest needs for the large pharmaceutical and biotechnology companies as well as academic laboratories which can profile new preclinical/clinical drug candidates (small molecules, peptides, biologics, mAb, vaccines) targeting immuno-related diseases for translational potential assessment and better predictive activity in clinical studies.. TransCure bioServices is your one stop shop for in vivo pharmacology preclinical expertise.